Macrophage-based therapeutic approaches for cardiovascular diseases Marida SansonettiBashar Al SoodiMira Jung Review Open access 03 January 2024 Pages: 1 - 33
Macrophage profiling in atherosclerosis: understanding the unstable plaque Ioanna GianopoulosStella S. Daskalopoulou Review 20 January 2024 Pages: 35 - 56
Targeted ablation of the left middle cervical ganglion prevents ventricular arrhythmias and cardiac injury induced by AMI Meng ZhengSiyu ChenZhibing Lu Original Contribution 28 December 2023 Pages: 57 - 74
Mast cell stabilizer, an anti-allergic drug, reduces ventricular arrhythmia risk via modulation of neuroimmune interaction Yuhong WangZhihao LiuLilei Yu Original Contribution 03 January 2024 Pages: 75 - 91
Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes Amelie PaascheFelix WiedmannConstanze Schmidt Original Contribution Open access 03 January 2024 Pages: 93 - 112
Pinacidil ameliorates cardiac microvascular ischemia–reperfusion injury by inhibiting chaperone-mediated autophagy of calreticulin Muyin LiuSu LiJunbo Ge Original Contribution Open access 02 January 2024 Pages: 113 - 131
Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice Qiuyu SunCory S. WaggGary D. Lopaschuk Original Contribution 26 December 2023 Pages: 133 - 150
Striated preferentially expressed gene deficiency leads to mitochondrial dysfunction in developing cardiomyocytes Gu LiHe HuangMark A. Perrella Original Contribution Open access 26 December 2023 Pages: 151 - 168
Thrombospondin 1 and Reelin act through Vldlr to regulate cardiac growth and repair Lijuan PeiZhaohui OuyangKe Wei Original Contribution 26 December 2023 Pages: 169 - 192